Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05878210 · ClinicalTrials.gov registry record
Evaluating the SUBLOCADE Treatment Exit Strategy
A clinical trial, sponsored by Indivior.
- Completed
- Registry status
- 12
- Enrollment target
NCT05878210 is a clinical trial that has completed, run by Indivior. The registered enrollment target is 12 participants.
The verdict
NCT05878210 has completed, sponsored by Indivior.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to observe and assess the successful taper and opioid withdrawal experience after participants stop receiving SUBLOCADE because their healthcare provider determines their disease symptoms have been controlled for at least 9 months and they, together with their healthcare provider, plan to discontinue MOUD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-11-24 |
| Est. Completion | 2025-05-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05878210
The ClinicalTrials.gov registry entry for NCT05878210 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indivior, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05878210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05878210 about?
NCT05878210 is a clinical study titled "Evaluating the SUBLOCADE Treatment Exit Strategy". The purpose of this study is to observe and assess the successful taper and opioid withdrawal experience after participants stop receiving SUBLOCADE because their healthcare provider determines their disease symptoms have been controlled for at least 9 months and they, together with their healthcare...
What is the current status of trial NCT05878210?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2023-11-24. Estimated completion is 2025-05-09.
Who is sponsoring clinical trial NCT05878210?
This trial is sponsored by Indivior, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.